← SynDRA
FG-2216
SynDRA canonical compound SYN0044839 — structure-anchored drug synonym record
| Clinical phase | Phase 2 |
|---|
| Primary target(s) | EGLN1 | EGLN2 | HIF1A |
|---|
| Mechanism of action | hypoxia inducible factor prolyl hydroxylase inhibitor |
|---|
All known targets
Mechanisms of action (all sources)
- hypoxia inducible factor prolyl hydroxylase inhibitor
Cross-references
Synonyms
- RU921DS4Z5
- FG2216
- 2-[(1-chloro-4-hydroxyisoquinolin-3-yl)formamido]acetic acid
- 2-((1-chloro-4-hydroxyisoquinolin-3-yl)formamido)acetic acid
- RefChem:599181
- FG 2216 (erythropoietic agent)
- (1-chloro-4-hydroxyisoquinoline-3-carbonyl)glycine
- N-[(1-Chloro-4-hydroxy-3-isoquinolinyl)carbonyl]glycine
- N-[(1-CHLORO-4-HYDROXYISOQUINOLIN-3-YL)CARBONYL]GLYCINE
- MFCD23136998
- IOX3;YM311
- 2-(1-chloro-4-hydroxyisoquinoline-3-carboxamido)acetic acid
- YM 311
- UN9
- IOX3; YM-311
- UNII-RU921DS4Z5
- Isoquinoline 3
- 4bqx
- OUQVKRKGTAUJQA-UHFFFAOYSA-N
- 4ie6
- Glycine, N-[(1-chloro-4-hydroxy-3-isoquinolinyl)carbonyl]-
- IOX3
- SCHEMBL522744
- orb1305475
- SCHEMBL29390250
- 2y34
- GLXC-90112
- EX-A2247
- YIA38775
- BIQ, >=98% (HPLC)
- BDBM50193145
- s7979
- AKOS026750490
- CCG-267248
- CS-4210
- EBC-251094
- FG2216?
- FG-2216; YM-311
- NCGC00480817-02
Look up FG-2216 in the interactive SynDRA portal →